2026 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

2026 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
Jan 24, 2026
Last Review
Jan 24, 2026
Expires
Jan 24, 2027

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

Faculty & Disclosure

Faculty

Mark Pegram, MD

Accreditation

NA